RHOQP2

Across TCGA pan-cancer cohorts, RHOQP2 RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated RHOQP2 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher RHOQP2 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RHOQP2 expression acts as an unfavorable survival marker, although some lineages such as LUAD and PRAD show a favorable association.

LUAD, LGG, and UVM are the cancer types where RHOQP2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Quartile	III,IV	0.753	0.388	.001	75	view →
LGG	OS	Median	All	0.736	0.886	<.001	53	view →
UVM	DFS	Quartile	III,IV	0.183	0.793	.001	50	view →
PRAD	DFS	Tertile	All	0.945	0.834	<.001	20	view →
SARC	OS	Median	All	0.803	0.685	.011	17	view →
ACC	OS	Tertile	III,IV	0.511	1.000	.013	15	view →
COAD	OS	Tertile	II,III,IV	0.933	0.807	.022	13	view →
BLCA	OS	Median	All	0.262	0.573	.008	12	view →
LAML	DFS	Tertile	All	0.323	0.593	.015	10	view →
CESC	DFS	Quartile	All	0.311	0.682	.012	10	view →
LIHC	OS	Tertile	All	0.623	0.782	.006	9	view →
KICH	OS	Quartile	II,III,IV	0.422	0.874	.013	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

RHOQP2–LUAD (DFS)

Open the LUAD breakdown →